Visus Therapeutics

0 followers

‌

Visus Therapeutics is a clinical-stage company in pursuit of developing the world’s first presbyopia-correcting eye drop with the potential to last at least eight hours.

Industries

Headquarters

Employees

Links

Org chart

Ben Bergo

CEO

Ben Bergo

Collapse

Rhett Schiffman

Chief Medical Officer & Head of R&D

Tim Grinstead

COO

David Toll

CFO

Lisa Simpson

VP, Clinical Operations & Compliance

Andy Firpo

VP, Information Technology

Patrick Hughes

VP, Pharmaceutical Development

Esther Cuno

VP, Human Resources

Robert Boxeth

Senior Quality Assurance Specialist

Kate Bishop

AVP, Legal & Intellectual Property

Dell Larned

Associate Director, Project Management

Dixie-Lee Shurland

Project Manager

Teams

Leadership Team

9 members

Clinical Operations Team

8 members

Clinical Operations Team

5 members

Accounting and Finance

4 members

Project Management Team

3 members

Similar companies

Vaxcyte

2 followers

Kyverna Therapeutics

5 followers

Vizgen

1 follower

Chroma Medicine

1 follower

EvolveImmune Therapeutics

1 follower

Applied Therapeutics

1 follower

Metagenomi

2 followers

Thermo Fisher Scientific

143 followers

Genentech

144 followers

Gilead Sciences

121 followers

Biogen

108 followers

Discover companies